Zolpidem Tartrate (B0207b5f 53fa 4b2c 8608 4095874aff98 01)
Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71335-2085
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71335-2085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Im-2 (B0207b5f 53fa 4b2c 8608 4095874aff98 02)
This is a chart displaying the plasma concentrations of zolpidem, a medication commonly used for insomnia treatment. The chart displays data points for the 12.5 mg extended-release tablets and the 10 mg immediate-release tablets. The x-axis measures time in hours, and the y-axis measures the plasma concentration of the medication in ng/mL. There is no additional information available in the provided text.*
Label (Lbl713352085)
This appears to be a label for a medication. The medication is compared to Ambien CR 6.25mg and comes in tablet form. The label lists a company named Lupin Limited and an NDC number. It also warns that the medication may cause dizziness or drowsiness and should be stored at room temperature. There is an address listed for Bunbank, but it is unclear what this refers to. Finally, there is a string of numbers that may be a product code.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
